Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial.

  • 2023-08-23
  • Gut microbes 15(2)
    • Xiaoqin Li
    • Shan Hu
    • Jiawei Yin
    • Xiaobo Peng
    • Lei King
    • Linyan Li
    • Zihui Xu
    • Li Zhou
    • Zhao Peng
    • Xiaolei Ze
    • Xuguang Zhang
    • Qiangchuan Hou
    • Zhilei Shan
    • Liegang Liu

Study Design

Type
Randomized Controlled Trial (RCT)
Population
106 healthy adults
Methods
double-blind, randomized, placebo-controlled study; participants randomly assigned to receive either synbiotics (containing Bifidobacterium lactis HN019 1.5×10^8 CFU/d, Lactobacillus rhamnosus HN001 7.5×10^7 CFU/d, and fructooligosaccharide 500 mg/d) or placebo for 8 weeks
Blinding
Double-blind
Duration
8 weeks
Funding
Unclear
Synbiotics are increasingly used by the general population to boost immunity. However, there is limited evidence concerning the immunomodulatory effects of synbiotics in healthy individuals. Therefore, we conducted a double-blind, randomized, placebo-controlled study in 106 healthy adults. Participants were randomly assigned to receive either synbiotics (containing Bifidobacterium lactis HN019 1.5 × 108 CFU/d, Lactobacillus rhamnosus HN001 7.5 × 107 CFU/d, and fructooligosaccharide 500 mg/d) or placebo for 8 weeks. Immune parameters and gut microbiota composition were measured at baseline, mid, and end of the study. Compared to the placebo group, participants receiving synbiotic supplementation exhibited greater reductions in plasma C-reactive protein (P = 0.088) and interferon-gamma (P = 0.008), along with larger increases in plasma interleukin (IL)-10 (P = 0.008) and stool secretory IgA (sIgA) (P = 0.014). Additionally, synbiotic supplementation led to an enrichment of beneficial bacteria (Clostridium_sensu_stricto_1, Lactobacillus, Bifidobacterium, and Collinsella) and several functional pathways related to amino acids and short-chain fatty acids biosynthesis, whereas reduced potential pro-inflammatory Parabacteroides compared to baseline. Importantly, alternations in anti-inflammatory markers (IL-10 and sIgA) were significantly correlated with microbial variations triggered by synbiotic supplementation. Stratification of participants into two enterotypes based on pre-treatment Prevotella-to-Bacteroides (P/B) ratio revealed a more favorable effect of synbiotic supplements in individuals with a higher P/B ratio. In conclusion, this study suggested the beneficial effects of synbiotic supplementation on immune parameters, which were correlated with synbiotics-induced microbial changes and modified by microbial enterotypes. These findings provided direct evidence supporting the personalized supplementation of synbiotics for immunomodulation.

Research Insights

Back to top